Julia Maurer

Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients

Additional file 1 of Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients

Additional file 1 of Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients

Feasibility of Adjuvant Radiotherapy or Chemoradiation for Elderly Patients with Squamous Cell Carcinoma of the Head and Neck, and Its Correlation with Different Comorbidity Scores: A Retrospective Cohort Study

Dietary habits in relation to outcome and therapy-related toxicity in patients with glioblastoma – a retrospective cohort study

P14.04.A CHARACTERISTIC FEATURES OF PATIENTS WITH AUTOIMMUNE DIFFERENTIAL DIAGNOSES FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)

The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of Germany

Systematic development of a patient-reported ONCOlogical-ROUTinE-Screening (ONCO-ROUTES) procedure at the University Cancer Center Regensburg

Entwicklung eines digitalen onkologischen Routinescreenings (ONCO-ROUTES) am Universitären Onkologischen Zentrum Regensburg (UCC-R)

A database for oncological research and quality assurance: implementation and first experiences with the University Clinical Cancer Registry Regensburg

Development of a patient-reported ONCOlogical-ROUTinE-Screening (ONCO-ROUTES) procedure and its digital implementation at the University Cancer Center Regensburg

Head and neck oncology management in the time of COVID-19: results of a head and neck cancer center

Angst und Depressivität bei Tumorpatienten im Verlauf der radioonkologischen Behandlung